Iguana Healthcare Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Iguana Healthcare Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.69M	Buy	+55,000	New	+$1.53M	1.11%	37

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Iguana Healthcare Management's MRTX Position: Q1 2018 in Review

Iguana Healthcare Management opened a new position in Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2018: 55,000 shares worth $1.69M. The stake represents 1.11% of the portfolio and ranks #37 among its holdings.

81 funds tracked by Wall St. Rank hold MRTX as of Q1 2018.

Iguana Healthcare Management held 55,000 shares of Mirati Therapeutics, Inc. Common Stock worth $1.69M as of Q1 2018.
Mirati Therapeutics, Inc. Common Stock was a new Iguana Healthcare Management position in Q1 2018.
Mirati Therapeutics, Inc. Common Stock made up 1.11% of Iguana Healthcare Management's portfolio in Q1 2018, its #37 holding.
81 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.